(Q44503073)

English

Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection.

scientific article published on 5 April 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23556551%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23556551%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Helicobacter pylori

1 reference

based on heuristic

inferred from title

eradication of infectious diseases

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Javier P Gisbert

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23556551%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Alicia C Marín

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23556551%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Adrian G McNicholl

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23556551%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Javier Molina-Infante

2

object named as

Javier Molina-Infante

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23556551%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Gemma Vinagre

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23556551%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Jesus Barrio

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23556551%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

publication date

5 April 2013

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23556551%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Scandinavian Journal of Gastroenterology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23556551%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

48

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23556551%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23556551%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

652-656

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23556551%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori.

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.786132

21 January 2018

Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori.

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.786132

21 January 2018

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.786132

21 January 2018

Sequential or concomitant therapy for Helicobacter pylori eradication?

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.786132

21 January 2018

The TETRA study: a prospective evaluation of Helicobacter pylori 'test-and-treat' strategy on 736 patients in clinical practice

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.786132

21 January 2018

Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail.

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.786132

21 January 2018

Helicobacter pylori and antibiotic resistance

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.786132

21 January 2018

Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.786132

21 January 2018

Efficacy of Helicobacter pylori eradication therapies: a single centre observational study

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.786132

21 January 2018

Regular review: treatment of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.786132

21 January 2018

Levofloxacin based triple therapy as a second-line treatment after failure of Helicobacter pylori eradication with standard triple therapy

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.786132

21 January 2018

A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses.

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.786132

21 January 2018

A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.786132

21 January 2018

Levofloxacin- versus metronidazole-based rescue therapy for H. pylori infection in Japan

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.786132

21 January 2018

Rescue Therapy for Helicobacter pylori Infection 2012.

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.786132

21 January 2018

Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure.

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.786132

21 January 2018

Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.786132

21 January 2018

Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.786132

21 January 2018

Second-line therapy with levofloxacin after failure of treatment to eradicate helicobacter pylori infection: time trends in a Spanish Multicenter Study of 1000 patients

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.786132

21 January 2018

Guide regarding choice of second-line therapy to obtain a high cumulative cure rate.

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.786132

21 January 2018

Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.786132

21 January 2018

Levofloxacin-based triple therapy for Helicobacter pylori re-treatment: role of bacterial resistance

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.786132

21 January 2018

Efficacy of H. pylori eradication with a sequential regimen followed by rescue therapy in clinical practice

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.786132

21 January 2018

A case of nonresected gastric cancer with peritoneal dissemination maintained on TS-1, cisplatin (CDDP) and docetaxel combination chemotherapy with good QOL

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.786132

21 January 2018

Failure of sequential therapy to eradicate Helicobacter pylori in previously treated subjects

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.786132

21 January 2018

Triple vs. quadruple therapy for treating Helicobacter pylori infection: a meta‐analysis

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.786132

21 January 2018

Nitrofuran-based regimens for the eradication of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.786132

21 January 2018

Furazolidone therapy for Helicobacter pylori: is it effective and safe?

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.786132

21 January 2018

Furazolidone in Helicobacter pylori therapy: misunderstood and often unfairly maligned drug told in a story of French bread

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.786132

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2013.786132

21 January 2018

Identifiers

10.3109/00365521.2013.786132

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23556551%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23556551%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44503073&oldid=1855155466"